Vo Thomas T. 4

What Happened
Thomas T. Vo, Chairman and CEO of Nutex Health (NUTX), had 8,334 restricted stock units (RSUs convert 1:1 to common stock) vest and be issued on March 10, 2026. Of those, 3,017 shares were sold to cover tax withholding obligations for proceeds of about $260,133 (sale price $86.22 per share). On March 11, 2026 he was also granted 4,841 new RSUs that vest in three equal installments on March 1, 2027, March 1, 2028 and March 1, 2029.

Key Details

• Transaction dates: RSU conversion and tax‑withholding sale dated March 10, 2026; new RSU grant dated March 11, 2026. Form 4 filed March 11, 2026.
• Conversion: 8,334 RSUs converted to 8,334 shares (acquired at $0 per share under RSU conversion).
• Tax withholding sale: 3,017 shares sold at $86.22 each, netting $260,133 (code F = tax withholding).
• New award: 4,841 RSUs granted (code A), vesting in three equal annual installments starting March 1, 2027.
• Shares owned/controlled after transaction (reported): Micro Hospital Holding LLC directly owns 1,840,898 shares and Vo Family LP directly owns 23,914 shares — a total of 1,864,812 shares reported as controlled by Mr. Vo.
• Footnotes: RSUs convert one‑for‑one to common stock; the 3,017‑share sale was to satisfy tax withholding; the 4,841 RSUs are time‑vested grants.
• Filing timeliness: Form 4 was filed March 11, 2026, reporting transactions from March 10, 2026 (within typical Form 4 timing).

Context
This was largely routine RSU activity: vested units converted to shares and a portion sold specifically to cover taxes (a common automatic withholding/sale), not an open‑market investment decision. The new 4,841 RSU grant is time‑based and vests over the next three years, which is a retention‑style award rather than an immediate purchase. The large share totals reported reflect ownership through entities controlled by Mr. Vo and are not indicative of additional open‑market buying or selling beyond the tax withholding.